DELAVENNE, Emilie Flora Aurore,SIMON, Daniel Jean Jacques,SOMMER, Morten Otto Alexander,TOFT-KEHLER, Rasmus Vendler
申请号：
PH12017500463
公开号：
PH12017500463A1
申请日:
2017.03.10
申请国别(地区):
PH
年份:
2017
代理人:
摘要：
The invention relates to a halogenated salicylanilide selected from closantel, rafoxanide, oxyclozanide and niclosamide and derivatives thereof including salts, hydrates, esters and the like for use in the topical treatment or prevention of infections caused by Gram-positive bacteria such as Staphylococcus, in particular Staphylococcus aureus, and Streptococcus, in particular Streptococcus pyogenes. Gram positive bacteria treated with the halogenated salicylanilides exhibit a very low frequency of appearance of resistant mutants compared to commonly used topical antibiotics.
